ASAP Regional Training on Epidemiological and Economic Tools for HIV/AIDS Strategic Planning S P ECONOMIC EVALUATION IN HEALTH CARE

Similar documents
ASAP Regional Training on Epidemiological and Economic Tools for HIV/AIDS Strategic Planning S P ECONOMIC EVALUATION IN HEALTH CARE

Economic Evaluations in Health An introduction for clinicians, researchers, and policy makers

Introduction of Health Economics

Economic Evaluation of Health Care

Economic Evaluation: Making the case for diabetes selfmanagement

Modelling and Health Economics

Overview of Pharmaco- Economics Methodologies Maher Hassoun, M.S.

Step by step guide to economic evaluation in cancer trials

Efficiency: Concepts and Methods. Hui Ru Chang Department of Medical Affairs, Mackay Memorial Hospital May 25, 2010

Introduction to Pharmacoeconomics. Almut G. Winterstein, Ph.D.

COSTING INTERVENTIONS

LARC: Return on Investment Virtual Learning Session. August 2, :00-4:00p ET For Audio: , ext #

Using the OneHealth tool for planning and costing a national disease control programme

AN OVERVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH

Allowing for differential timing in cost analyses: discounting and annualization

Recommendations of the Panel on Cost- Effectiveness in Health and Medicine

Health Economics 3. Competition in Health Care Evaluation of Health & Life

Gates Reference Case: background, structure and content

Health Economics Workshop: Costing Tools. Monisha Sharma, PhD International Clinical Research Center (ICRC) University of Washington

ECONOMIC VALUE OF VACCINES

Economic evaluations are defined as the comparative analysis of alternative

Economics & Efficiency The supply side: resources, production, costs

PUBLIC PROJECT DESIGN AND EVALUATION. 04_CBA (Cost-Benefit Analysis) Gabriela Vaceková

Economics Concepts Overview

LIHS Mini Master Class

What can Health Economics do for you?

Results Based Financing for Health Impact Evaluation Workshop Tunis, Tunisia October Evaluating the Cost and Financial Impact of RBF Schemes

Thirty-Second Board Meeting Corporate KPIs Narrative

The broader economic impact of healthcare: Assessing healthcare as

POLISH GUIDELINES FOR CONDUCTING PHARMACOECONOMIC EVALUATIONS. (project)

Introduction to Economic Evaluation. AEA/CDC Summer Evaluation Institute 2011

HSPM 818: Economic Evaluation and Policy Analysis of Health Services. Fall Semester 2011, Week 1: Introduction Assistant Professor Brian Chen

Session 2.2 Project Alternatives, Least Cost and Cost Effectiveness Analyses

Valuing Medical Innovation Perspectives matter. Lara Verdian 10 September 2015

Economic Evaluation Abstraction Form Version 4.0 (last update: June 2010)

Introduction to Health Economics. Educational Seminar ISPOR Dubai - September 19, 2018

Health Sector Strategy. Khyber Pakhtunkhwa

COSTING AN OPERATIONAL PLAN Costing Concepts and Methodology

Introduction to key concepts and definitions

Guidelines for cost and cost-effectiveness analysis of tuberculosis control DOCUMENT

HTA and Submissions. Ferg Mills, Angela Rocchi April 5, Agenda

UNICEF s equity approach: from the 2010 Narrowing the Gaps study via equity focused programming and monitoring to a Narrowing the Gaps+5 study &

Booklet A1: Cost and Expenditure Analysis

How should funds for malaria control be spent when there are not enough?

NATIONAL POLICY IN HEALTH FINANCING

Incorporating Economic Evaluation in Clinical & Translation Research. Setting expectations. Why bother with economic evaluation? Introduction 10/9/17

Health and Wellbeing GSK s Partnership for Prevention Programme

for example, Medicare reimbursement rates, you're just looking at this issue from Medicare's point of view, what's the cheapest way to go about doing

Methodology to assess the cost impact of PMB benefit definitions

PROJECT CRITERIA: ECONOMIC VIABILITY AND PROJECT ALTERNATIVES

CSBAG Position paper on Health Sector BFP FY 2016/17

Cost-Benefit Analysis in the study of the effectiveness of health programs

Production Gains from Health Care: What Should be Included in Cost-effectiveness Analyses?

Valuing Health Outcomes

BOTSWANA BUDGET BRIEF 2018 Health

OVERVIEW OF DETAILED APPRAISAL PROCESS

ACCESS TO THE HIGHEST QUALITY PRIMARY HEALTHCARE AT AFFORDABLE PRICES

Playing games with transmissible animal disease. Jonathan Cave Research Interest Group 6 May 2008

OneHealth Tool. Health Systems Financing Department

Decision Analysis to Guide Policy on the Introduction of a Routine Second Dose of Measles Vaccine

SANADI PLAN BY NATIONAL BONDS. Terms & conditions apply CAMERA / PLAN AHEAD. PROTECT YOUR FUTURE.

Cost-Effectiveness Analysis: The Bare Essentials

HEALTH BUDGET SWAZILAND 2017/2018 HEADLINE MESSAGES. Swaziland

Value-Based Pricing Working Party #1: Briefing for DH presentation

The Economics of Healthcare-Associated Infections Dr. Doug Scott, CDC Sponsored by Virox Technologies Inc.

The Global Economy and Health

Evaluation of the Low-Income Pool Program Using Milestone Data: SFY

HUNTSVILLE PEDIATRIC AND ADULT MEDICINE ASSOCIATES PATIENT INFORMATION

Frameworks to Set Priorities for Treatments Based on Cost-Effectiveness and Equity

Economic Impact of HIV/AIDS

Incorporating Health Inequality Impacts into Cost-Effectiveness Analysis

Performance-Based Intergovernmental Transfers

rff report Valuing Health Outcomes: Policy Choices and Technical Issues Executive Summary Alan J. Krupnick MARCH 2004

presented by ASUMMARY

Chapter 27 Health and Life Insurance Name

A framework for measuring the impact of HTA policy interventions. Eleanor Grieve University of Glasgow July 2015

Intervention costing in OneHealth: Concepts related to Population in Need, Target Population and Coverage

LESOTHO HEALTH BUDGET BRIEF 1 NOVEMBER 2017

Securing Sustainable Financing: A Priority for Health Programs in Namibia

Effect of costing methods on unit cost of hospital medical services; A case of capital cost

Data Profile of Sagar District

January 31, Dear Mr. Larsen:

National Health Policies, Strategies and Plans and costing (NHPSP)

3.0 APPROACH TO THE ECONOMIC ANALYSIS

Scaling up interventions in the Eastern Mediterranean Region. What does it take and how many lives can be saved?

BOSTON WEALTH MANAGEMENT, LLC

Universal Health Coverage and Sustainable Development. David B Evans, Director Health Systems Financing

Programme Budget Matters: Programme Budget

Background The Health Impact Fund (HIF) Characteristics of the HIF Progress

Health Systems in Developing Countries IAA Health Section Colloquium. Lisa Beichl International Health Consultant

THE FIRM AND ITS GOALS. Dr. Mohammed Alwosabi

Clinical Research in HIV/ AIDS

The (Near) Equivalence of Cost-Effectiveness and Cost-Benefit Analyses Fact or Fallacy?

Quality of Health Care and the Design of the Basic Benefit Package Lessons from Overseas

What you need to know

Measuring costs related to the provision of health services for young people

Fiscal Implications of Chronic Diseases. Peter S. Heller SAIS, Johns Hopkins University November 23, 2009

This study applied various macroeconomic

Introduction to Control Knobs

3.0 APPROACH TO THE ECONOMIC ANALYSIS

Transcription:

ASAP Regional Training on Epidemiological and Economic Tools for HIV/AIDS Strategic Planning ECONOMIC EVALUATION IN HEALTH CARE

Outline of the Session 1. What is Economic Evaluation? 2. Why do Economic Evaluation? 3. What is Costing useful for? 4. Types of Economic Evaluation (EE) approaches a) Cost- Minimization Analysis b) Cost- Effectiveness Analysis c) Cost- Benefit Analysis d) Cost- Utility Analysis 5. Some Outcome Measures 6. Other issues (uncertainty, limitations of EE) 7. How you will make use of EE information

What is Economic Evaluation? Definition: the comparative analysis of alternative courses of action in terms of both their cost and consequences. Drummond, M. F. et al. 1997 It involves gathering and examining data about choices (interventions/programs) so they can be assessed.

Why do Economic Evaluation? Improve strategies, programs, and interventions so you get the best value for your money and effort Make more informed decisions in future planning Clarify the options available Account for the expenditure of funds

What Is Economics? Economics is the study of the choices made by people who are faced with scarcity or choosing how to use scarce resources that have alternative uses. Tunis, Jan 28-30, 2009

Economic Cost In economics, the notion of a firm s s costs is based on the notion of economic cost. The key principle underlying the computation of economic cost is the principle of opportunity cost. Tunis, Jan 28-30, 2009

Why Do Economic Evaluation? To assist in choosing between options An aid to decision-making, not a substitute for thought E.g. comparing different HIV prevention programs in terms of their cost and their effectiveness in preventing new HIV cases cost per HIV-case prevented E.g. comparing different HIV treatment programs in terms of their effectiveness in extending life and their cost cost per Life Year Gained

What is costing useful for? Determining the resource requirements of an intervention Identifying costs and potential savings e.g. the optimal use of personnel in health care delivery Budgeting & Strategic Planning Assessing efficiency in two equivalent programs Which one yields the greatest benefit with a given amount of resources

Types of Economic Evaluation Four main techniques: Cost-minimization analysis Cost-benefit analysis Cost-effectiveness analysis Cost-utility analysis All attempt to compare the inputs with the outputs All use similar costing methods to estimate the inputs Main distinction = way in which outcomes (benefits) are evaluated Each has advantages and disadvantages selection depends on the question you are asking and the alternatives you are comparing

Accounting Versus Economic Cost An accountant s notion of costs involves only the patient s explicit costs. Explicit cost: the patient s actual cash payments for its inputs. An economist includes the patient s implicit costs. Implicit cost: the opportunity cost of nonpurchased inputs. Economic cost: the sum of explicit cost plus implicit cost. Tunis, Jan 28-30, 2009

Types of Costs 1. Direct Costs: all the cost incurred in delivering the health service (i.e. hospitalization) 2. Direct Non-medical costs: (i.e., transport, lodging at the site) 3. Indirect costs: those additional costs, usually from the perspective of the patient, in accessing the health service (lost productivity) 4. Intangible Costs: those difficult to identify and measure eg. illness, depression, loss of quality of life (pain and suffering) Tunis, Jan 28-30, 2009

Cost-minimization analysis (CMA) Outcomes between two or more alternatives are identical (e.g. exactly the same number of life-years gained) Thus the evaluation aims to identify the least costly (cheapest) intervention Only addresses technical efficiency & costs of inputs. Technical efficiency is a term used by economist to mean that resources are not wasted in the production process. CMA is limited in use because it is not common for the outputs to be exactly the same

Cost-effectiveness analysis (CEA) Probably the most used approach. When the outcomes of the different interventions are different but can be measured in the same terms (natural units) then the inputs are costed. For example: CEA of different interventions for averting heart attacks CEA of different ARV regimens for HIV+ adults Competing interventions are compared in terms of cost per unit of consequence e.g cost per patient with and without heart attack. The measures of outcome have to be common to all alternatives to allow comparison.

Cost-benefit analysis (CBA) Measures all costs and benefits in dollar terms You can compare any program with any other program Costs and benefits (effects) of an intervention are both valued in monetary terms ($$$) e.g. CBA can give information on whether a health intervention should be funded based on societal gains, in comparison to other health programs e.g. mass vaccination program for measles. CBA allows comparison of programs between health care and other sectors (allocative efficiency). If the benefits of implementing the intervention are greater than the costs, then the program should be funded. CBAs are used infrequently in health care because it is difficult of expressing health benefits directly in monetary units

Cost-utility analysis (CUA) Lies between CEA and CBA assesses technical efficiency (doing it right) as well as allocative efficiency (Obtaining the most consumer satisfaction from available resources. Resources are allocated in such a way that consumer satisfaction is at its highest possible level. ) but only within the health care sector Benefits expressed in terms of a multidimensional unit of outcome (e.g. QALYs or DALYs etc). This measure of outcome combines values of mortality and morbidity with values based on preferences of patients and related individuals regarding health states. Interventions are compared in terms of cost per unit of utility gained

Some outcome measures The consequences/ results of an intervention. It can be a specific outcome of the intervention but refers to an overall Health Improvement There are various nonmutually exclusive classifications of outcomes: Direct, Indirect and Intangible Final and intermediate outcomes Natural /physical units and utility / generic units Some examples Deaths averted Condom use increase Malaria cases prevented Fully Immunized Children QALYs gained DALYs averted Life years gained Reduction of pain Levels of cholesterol reduced HIV cases avoided Increase in productivity at work Number of VCT sites per 10,000 population Healthy Years Equivalent

HIV & Immunization Outcomes In costing we identify and measure all the inputs and all the outputs or benefits of the cost. Some examples: HIV treatment programmes: cost per life year gained HIV prevention programmes: cost per HIV case prevented Immunisations: cost per Fully Immunised Child (FIC) Immunisations: cost per measles case prevented/death prevented Malaria ACT treatment: cost per cured case Tunis, Jan 28-30, 2009

Simplified criteria to guide decision-making for cost-effectiveness 1. Alternative is less costly and less effective 2. Alternative is less costly and more effective (this strategy dominates) 3. Alternative is more costly but less effective (this strategy is dominated) 1. It is more costly but also more effective; if the extra cost is worth the extra benefit then choose this alternative

Increasing cost Every point in this box is dominated by point A Less effective, less expensive A More effective, more expensive Every point in this box is dominates point A Increasing effectiveness

Summary Economic Evaluation is a useful tool for resource allocation Accounting for uncertainty Sometimes we cannot be certain about some aspects of the economic evaluation, especially future costs (e.g. inflation rate) and benefits Sensitivity analysis: use a range of estimates based on different assumptions to assess if changes in the value of a variable will affect the results of the analysis for both costs and effects In some cases cost-effectiveness/utility criteria needs to be complemented by other important considerations: ethics, equity, etc.

Key messages Economic evaluation is an aid or tool to decision-making, not a substitute for thought Select type of economic evaluation based on the question to be addressed Always remember and account for uncertainty in the results

References for Economic Evaluation Drummond M, Stoddart G, Torrance G (1987) Methods for the Economic Evaluation of Health Care Programmes, Oxford: Oxford University Press Gold M, Siegel J, Russell L and Weinstein M (1996) Cost-Effectiveness in Health and Medicine, Oxford: Oxford University Press Miller, Paul (2001) Health Economic Evaluation, Trent Focus for Research and Development in Primary Health Care. Available at: http://www.trentfocus.org.uk/resources/introduction_health _economic_evaluation.htm